0001104659-22-068189.txt : 20220603
0001104659-22-068189.hdr.sgml : 20220603
20220603180550
ACCESSION NUMBER: 0001104659-22-068189
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220531
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glass Geoffrey Michael
CENTRAL INDEX KEY: 0001517718
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 22996099
MAIL ADDRESS:
STREET 1: 4721 EMPEROR BLVD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4/A
1
tm2217506-3_4aseq1.xml
OWNERSHIP DOCUMENT
X0306
4/A
2022-05-31
2022-06-02
0
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001517718
Glass Geoffrey Michael
C/O AVADEL PHARMACEUTICALS PLC
10 EARLSFORT TERRACE
DUBLIN 2
L2
D02 T380
IRELAND
1
0
0
0
ADSs
2022-05-31
4
P
0
45000
2.14
A
45000
I
By Trust
The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by
American Depositary Receipts.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.10 to $2.16, inclusive. The Reporting
Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the
number of shares purchased at each separate price within the range.
These ADSs are held by The Geoffrey Glass Trust of which the reporting person is a co-trustee. The reporting person is the sole beneficiary of the trust.
The Form 4 filed on June 2, 2022 inadvertently reported that the transaction occurred on June 1, 2022. The transaction occurred on May 31, 2022.
/s/ Jerad G. Seurer, as Attorney-in-Fact
2022-06-03